We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 4 of 18 for:    isis AND huntington's

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02583919
Recruitment Status : Completed
First Posted : October 22, 2015
Last Update Posted : June 25, 2018
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 15, 2016
Actual Study Completion Date : May 11, 2017
Certification/Extension First Submitted : June 20, 2018